Efficacy and Safety of House Dust Mite Sublingual Immunotherapy Tablet in Allergic Asthma: A Systematic Review of Randomized Controlled Trials
- 15 February 2022
- journal article
- review article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 10 (5) , 1342-1355.e24
Abstract
No abstract availableKeywords
Funding Information
- Takeda Pharmaceutical Company
- GlaxoSmithKline
- Faculty of Medicine, Chiang Mai University
- Novartis
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Abbott Laboratories
- Sanofi
This publication has 35 references indexed in Scilit:
- Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trialJournal of Allergy and Clinical Immunology, 2016
- Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamberJournal of Allergy and Clinical Immunology, 2015
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile rangeBMC Medical Research Methodology, 2014
- SQ HDM SLIT-tablet (ALK) in treatment of asthma – Post hoc results from a randomised trialRespiratory Medicine, 2014
- Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trialJournal of Allergy and Clinical Immunology, 2014
- Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitisJournal of Allergy and Clinical Immunology, 2014
- Searching for grey literature for systematic reviews: challenges and benefitsResearch Synthesis Methods, 2013
- Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and AsthmaJAMA, 2013
- Assessment of sublingual immunotherapy efficacy in children with house dust mite‐induced allergic asthma optimally controlled by pharmacologic treatment and mite‐avoidance measuresPediatric Allergy and Immunology, 2007
- Dust mites: Immunology, allergic disease, and environmental controlJournal of Allergy and Clinical Immunology, 1987